A detailed history of Citigroup Inc transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Citigroup Inc holds 117,938 shares of RVMD stock, worth $5.11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
117,938
Previous 58,367 102.06%
Holding current value
$5.11 Million
Previous $2.27 Million 135.89%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$36.92 - $47.94 $2.2 Million - $2.86 Million
59,571 Added 102.06%
117,938 $5.34 Million
Q2 2024

Aug 12, 2024

SELL
$30.14 - $40.68 $6.61 Million - $8.92 Million
-219,308 Reduced 78.98%
58,367 $2.27 Million
Q1 2024

May 10, 2024

BUY
$26.56 - $33.55 $3.1 Million - $3.91 Million
116,634 Added 72.43%
277,675 $8.95 Million
Q4 2023

Feb 09, 2024

BUY
$18.35 - $34.12 $1.17 Million - $2.18 Million
63,807 Added 65.62%
161,041 $4.62 Million
Q3 2023

Nov 09, 2023

SELL
$25.17 - $35.05 $636,549 - $886,414
-25,290 Reduced 20.64%
97,234 $2.69 Million
Q2 2023

Aug 10, 2023

SELL
$20.28 - $27.0 $2.86 Million - $3.81 Million
-141,244 Reduced 53.55%
122,524 $3.28 Million
Q1 2023

May 11, 2023

BUY
$20.76 - $30.09 $3.26 Million - $4.72 Million
156,876 Added 146.76%
263,768 $5.71 Million
Q4 2022

Feb 09, 2023

SELL
$17.68 - $25.53 $2.44 Million - $3.53 Million
-138,253 Reduced 56.4%
106,892 $2.55 Million
Q3 2022

Nov 10, 2022

BUY
$17.46 - $26.0 $2.37 Million - $3.53 Million
135,598 Added 123.78%
245,145 $4.83 Million
Q2 2022

Aug 10, 2022

BUY
$14.54 - $27.17 $1.18 Million - $2.2 Million
80,987 Added 283.57%
109,547 $2.14 Million
Q1 2022

May 12, 2022

SELL
$17.31 - $26.4 $1.86 Million - $2.83 Million
-107,298 Reduced 78.98%
28,560 $729,000
Q4 2021

Feb 10, 2022

BUY
$24.35 - $33.7 $1.52 Million - $2.11 Million
62,564 Added 85.36%
135,858 $3.42 Million
Q3 2021

Nov 10, 2021

BUY
$23.95 - $33.41 $1.76 Million - $2.45 Million
73,294 New
73,294 $2.02 Million

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $3.8B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.